Merck hails rise in patient tests for immunotherapy drug Keytruda – Financial Times
Financial Times |
Merck hails rise in patient tests for immunotherapy drug Keytruda
Financial Times Merck recently became the first company to win regulatory approval to also use the drugs to treat some lung cancer sufferers that have not yet tried chemotherapy, giving it an edge in a three-way battle with rival immunotherapy makers Bristol-Myers … Merck unveils new Keytruda DTC ad Merck 2017 forecast reassuring; full-speed ahead with Keytruda Merck revenue declines as generics weigh |
